Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited)

v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Common stock, beginning balance (in shares) at Dec. 31, 2023   698,262,025      
Beginning balance at Dec. 31, 2023 $ 1,034,362 $ 70 $ 2,282,475 $ (1,247,703) $ (480)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (94,587)     (94,587)  
Stock-based compensation 35,328   35,328    
Issuance of common stock upon exercise of stock options (in shares)   1,016,414      
Issuance of common stock upon exercise of stock options 943   943    
Issuance of common stock upon release of restricted stock units (in shares)   6,034,056      
Vesting of early exercised stock options 186   186    
Other comprehensive loss (1,101)       (1,101)
Common stock, ending balance (in shares) at Mar. 31, 2024   705,312,495      
Ending balance at Mar. 31, 2024 $ 975,131 $ 70 2,318,932 (1,342,290) (1,581)
Common stock, beginning balance (in shares) at Dec. 31, 2024 784,176,364 784,176,364      
Beginning balance at Dec. 31, 2024 $ 912,363 $ 78 2,768,605 (1,855,737) (583)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (82,406)     (82,406)  
Stock-based compensation 27,019   27,019    
Issuance of common stock upon exercise of stock options (in shares)   807,475      
Issuance of common stock upon exercise of stock options 547   547    
Issuance of common stock upon release of restricted stock units (in shares)   4,063,821      
Issuance of common stock in at-the-market public offering, net of issuance cost of $19 (in shares)   246,167      
Issuance of common stock in at-the-market public offering, net of issuance cost of $81 1,994 $ 1 1,993    
Vesting of early exercised stock options 13   13    
Other comprehensive loss $ (89)       (89)
Common stock, ending balance (in shares) at Mar. 31, 2025 789,293,827 789,293,827      
Ending balance at Mar. 31, 2025 $ 859,441 $ 79 $ 2,798,177 $ (1,938,143) $ (672)